Metraipolis › archive › dc_2010149db49d

Microbiota-driven therapeutic efficacy of Hyperoside in ulcerative colitis and associated anxiety — Europe PMC PMID:41696361

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41696361
DOI
10.3389/fcimb.2026.1734356
License (as archived)
solo-consultazione
Archived
2026-11-06T11:03:02.364Z
SHA-256 of the archived text
6d6c5eb7db02db22cc97bfb2ac8bc5eedd0c207a3ff6a31a91ce53058b620021
Stable URL of this page
https://metraipolis.com/documento/dc_2010149db49d

How to cite

Microbiota-driven therapeutic efficacy of Hyperoside in ulcerative colitis and associated anxiety — Europe PMC PMID:41696361 — Europe PMC (en), https://europepmc.org/article/MED/41696361 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2010149db49d (Metraipolis archive dc_2010149db49d, sha256 6d6c5eb7db02db22cc97bfb2ac8bc5eedd0c207a3ff6a31a91ce53058b620021)
BibTeX
@misc{dc2010149db49d,
  title = {Microbiota-driven therapeutic efficacy of Hyperoside in ulcerative colitis and associated anxiety — Europe PMC PMID:41696361},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41696361},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2010149db49d; sha256 6d6c5eb7db02db22cc97bfb2ac8bc5eedd0c207a3ff6a31a91ce53058b620021},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41696361. Agents can read the archived copy with the MCP tool read_document.